SCHEMBL26567752

SCHEMBL26567752

Fc1ccc(-c2ccc3ccc(-c4ccc(-c5ccc(P)cc5)nc4)cc3c2)cc1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PGR P06401 1/20 0.42
NPC1 O15118 1/20 0.42
RXFP1 Q9HBX9 1/20 0.42
PDGFRB P09619 3/20 0.38
PDGFRA P16234 3/20 0.38
TDO2 P48775 2/20 0.38
IDO1 P14902 1/20 0.38
PTPN1 P18031 1/20 0.38
PTPN6 P29350 1/20 0.38
PTPN11 Q06124 1/20 0.38
HSD17B1 P14061 1/20 0.37
HSD17B2 P37059 1/20 0.37
CASP3 P42574 2/20 0.37
SENP8 Q96LD8 2/20 0.37
SENP7 Q9BQF6 2/20 0.37
SENP6 Q9GZR1 2/20 0.37
GRM5 P41594 1/20 0.36
CYP11B1 P15538 1/20 0.35
CYP11B2 P19099 1/20 0.35
AURKA O14965 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26548830 0.92 NPC1 (0.47) PGRNPC1RXFP1PDGFRBPDGFRA
SCHEMBL26552014 0.87 HSD17B1 (0.43) NPC1HSD17B1HSD17B2CASP3SENP7
SCHEMBL26548334 0.87 NPC1 (0.49) PGRNPC1RXFP1PDGFRBPDGFRA
SCHEMBL26555746 0.85 PDGFRB (0.39) NPC1PDGFRBPDGFRAHSD17B1HSD17B2
SCHEMBL26567788 0.85 PDGFRB (0.50) NPC1RXFP1PDGFRBPDGFRATDO2
SCHEMBL26548715 0.85 KDM4E (0.45) NPC1RXFP1PDGFRBPDGFRACYP11B1
SCHEMBL26554742 0.85 CYP19A1 (0.42) PDGFRBPDGFRAHSD17B1HSD17B2CYP11B1
SCHEMBL26567760 0.84 KDM1A (0.43) PGRTDO2IDO1HSD17B1HSD17B2
SCHEMBL26553797 0.83 PGR (0.55) PGRPDGFRBPDGFRANR3C1
SCHEMBL26548688 0.83 CYP1A2 (0.48) NPC1RXFP1PDGFRBPDGFRAHSD17B1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230337527-A1 ORGANIC COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING SAME LAPTO CO., LTD. (KR) 2023-10-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230337527-A1 ORGANIC COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING SAME AOC1, ODC1, PIEZO1 PGR 4012/4885NPC1 1199/4885RXFP1 4537/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.